Live Chat on The Biotech Forum has been dominated by discussion of covered call opportunities in recent quarters. To see what I and the other season biotech investors are targeting as trading ideas in real-time, just initiate your free trial into The Biotech Forum by clicking HERE .Today, I put Cytokinetics, Incorporated (NASDAQ: CYTK ) in the spotlight for the first time in 2025. I last posted research on this mid-cap biopharma in November 2024. The stock hit a bump when a snag occurred around the approval ...